For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
Blog
This week in health care policy: September 28 – October 2, 2026
Drug pricing CMS finalizes GLOBE pilot. On September 30, CMS finalized the Global Benchmark for Efficient Drug Pricing model, a…
Blog
This week in health care policy: September 21–25, 2026
Innovation watch FDA approves the first treatment for Sanfilippo syndrome. On September 17, the FDA approved Ultragenyx’s Fayuvi, a one-time…
Blog
How The No Surprises Act worsened the problem of surprise bills
Next week, Sen. Bill Cassidy (R-LA) will convene a roundtable to discuss adjustments to the 2020 No Surprises Act, which has come under…
Search Posts
Op-Eds
Rachel Carson’s legacy nothing to celebrate
Today is the centenary of Rachel Carson’s birth, which has been noted by many environmentalists who cherish her legacy. However, what has been little…
Blog
The Gotham Prize for Cancer
According to Reuters, medical researchers got together with hedge fund managers to institute the Gotham Prize for Cancer Research, a new private prize…
News Release
Another Revolution Needed For Biotech Medicines
Contact: Jody Clarke, 202.331.2252…
Blog
Rachel Was Wrong
Today we launch our campaign urging people to rethink the legacy of environmentalist icon Rachel Carson, with the site www.RachelWasWrong.com. Today she’s mostly remembered…
News Release
Rethinking the Rachel Carson Legacy
Washington, D.C., May 21, 2007—As environmentalists around the world prepare this week to celebrate the 100th birthday of author Rachel Carson, the Competitive Enterprise…
Blog
Tim Carney on Drugs
Our good friend Tim Carney writes in today’s Examiner about how Congress is pushing to expand the FDA’s authority over prescription drugs, and why…